Found 4 matching trials
KRAS-Targeted Vaccine With Chemoimmunotherapy, Nivolumab and Ipilimumab for Patients With NSCLC
PHASE1This is a single institution, Phase 1 study for patients with Stage III/IV ...
Location
Johns Hopkins University
Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer
PHASE1The purpose of this study is to determine the optimal dose of AGEN2373 that...
Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
PHASE1Phase 1b study evaluating the efficacy and immune response to a synthetic l...
Location
Sidney Kimmel Comprehensive Cancer Center
Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer
PHASE1This Phase 1 study will evaluate safety and the immune response to pooled m...
Location
Sidney Kimmel Comprehensive Cancer Center